Article 59BKX TB treatment: New shorter regimen identified in trial

TB treatment: New shorter regimen identified in trial

by
Press Release
from Outbreak News Today on (#59BKX)

By NewsDesk @bactiman63 Results from an international, randomized, controlled clinical trial indicate that a four-month daily treatment regimen containing high-dose, or optimized," rifapentine with moxifloxacin is as safe and effective as the existing standard six-month daily regimen at curing drug-susceptible tuberculosis (TB) disease. This regimen is the first successful short-course treatment regimen for drug-susceptible TB disease [...]

The post TB treatment: New shorter regimen identified in trial appeared first on Outbreak News Today.

OutbreakNewsToday?d=yIl2AUoC8zA OutbreakNewsToday?d=qj6IDK7rITs OutbreakNewsToday?d=63t7Ie-LG7Y
External Content
Source RSS or Atom Feed
Feed Location http://feeds.feedburner.com/OutbreakNewsToday
Feed Title Outbreak News Today
Feed Link https://outbreaknewstoday.com/
Feed Copyright The Global Dispatch, Inc
Reply 0 comments